In colon cancer, this molecule was integrated into a novel panel linked to metastasis and was stratified according to the prognostic risks of CRC, suggesting that the expression of ERP29 is strongly associated with cancer cell's metastasis and disease recurrence [25]. This evidence concerns the gene ERP29 and colonic neoplasm.